Clinical Trial Update: Amphotericin B Suspension in Refractory Chronic Sinusitis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating amphotericin B suspension for refractory chronic sinusitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sinusitis

Drugs mentioned

• Amphotericin B suspension (amphotericin B)

Snippet

Sponsor: Accentia Biopharmaceuticals | Conditions: Chronic Sinusitis | Phase 3 | Status: COMPLETED